Article thumbnail

Cost-effectiveness of first-line versus delayed use of combination dapagliflozin and metformin in patients with type 2 diabetes

By Ken Lee Chin, Richard Ofori-Asenso, Si Si, Thomas R. Hird, Dianna J. Magliano, Sophia Zoungas and Danny Liew
Publisher: Springer Nature
Year: 2019
DOI identifier: 10.1038/s41598-019-40191-8
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.nature.com/articles... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.